¿Primer pedido? Ahorra 20%.
(888) 510-7196
Volver
Caring SunshineIngredientes

nicotinamida ribósido

Condiciones de Salud21
Tabla de contenidos

Otros Nombres

1-(beta-D-Ribofuranosyl)nicotinamide1-beta-D-ribosyl-3-pyridinecarboxamide1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-(C-hydroxycarbonimidoyl)-1$l5-pyridin-1-ylium1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyridin-1-ium-3-carboxamide3-(aminocarbonyl)-1-beta-D-ribofuranosyl-pyridinium3-Carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium3-Carbamoyl-1-(beta-D-ribofuranosyl)pyridiniumbeta-nicotinamide D-ribosideN-ribosyl-nicotinamideN-ribosylnicotinamidenicotinamide ribonucleosidenicotinamide ribosenicotinamide riboside chloridenicotinamide-beta-D-ribofuranosidenicotinamide-beta-ribosideNRPyridinium, 3-(aminocarbonyl)-1-beta-D-ribofuranosyl-ribosylnicotinamideSR647SRT-647SRT647vitamin B3 (riboside form)

Sinopsis

Historia

El salvado, la capa exterior de los granos de cereales como el trigo, la avena y el arroz, ha ocupado un lugar significativo en la medicina tradicional de diversas culturas durante siglos. Históricamente, el salvado fue reconocido por su notable capacidad para promover la salud digestiva. Los sanadores griegos y romanos antiguos recomendaban panes y gachas enriquecidos con salvado como un remedio suave para el estreñimiento y los intestinos perezosos, aprovechando su alto contenido de fibra dietética. En la Europa medieval, el salvado se remojaba comúnmente en agua caliente para crear cataplasmas calmantes para las irritaciones de la piel y las heridas, lo que refleja sus aplicaciones externas e internas.

A lo largo de la historia, el salvado también ha sido valorado por su papel en el mantenimiento de la vitalidad general. Los remedios populares a menudo incorporaban el salvado en las dietas diarias para reforzar la fuerza, apoyar el metabolismo y mejorar la saciedad. En la Medicina Tradicional China, el salvado a veces se combinaba con otras hierbas para potenciar los efectos depurativos y desintoxicantes de las decocciones herbales, particularmente aquellas destinadas a apoyar la salud intestinal y la regularidad.

En las combinaciones herbales, el salvado sirve como ingrediente tanto funcional como sinérgico. Su fibra natural amplifica la eficacia de los botánicos conocidos por sus propiedades laxantes o calmantes, como la sen, la raíz de regaliz o la cáscara de psyllium. Al actuar como un agente formador de volumen suave, el salvado ayuda a que las hierbas actúen de manera más predecible y cómoda, reduciendo la probabilidad de irritación. Sus cualidades prebióticas apoyan además el crecimiento de la flora intestinal beneficiosa, complementando las acciones restauradoras de muchas mezclas herbales. En general, la inclusión del salvado en los remedios históricos y modernos subraya su valor perdurable como ayuda natural para el bienestar digestivo y la salud holística.

Validación tradicional y científica

El salvado, la capa exterior de los granos de cereales como el trigo, la avena y el arroz, ha sido valorado por sus propiedades nutricionales a lo largo de la historia. Tradicionalmente, el salvado era a menudo eliminado durante la molienda para producir harinas más finas, pero sus beneficios para la salud han llevado a su resurgimiento como ingrediente clave en los productos nutricionales modernos. Rico en fibra dietética, ácidos grasos esenciales, vitaminas y minerales, el salvado es especialmente notable por su contenido de fibra insoluble, que desempeña un papel significativo en la salud digestiva.

La investigación científica respalda los efectos positivos del salvado sobre la salud, particularmente en lo que respecta a la función gastrointestinal. Numerosos estudios clínicos han demostrado que las dietas ricas en salvado pueden ayudar a aumentar el volumen de las heces, reducir el estreñimiento y promover movimientos intestinales regulares. Por ejemplo, el salvado de trigo es ampliamente reconocido por su eficacia para aliviar el estreñimiento leve a moderado. Además, el salvado de avena contiene beta-glucano, una fibra soluble que ha demostrado en ensayos clínicos ayudar a reducir los niveles de colesterol sérico, apoyando así la salud cardiovascular.

Los estudios poblacionales también han vinculado una mayor ingesta de salvado con menores riesgos de enfermedades crónicas como la diabetes tipo 2 y ciertos cánceres, especialmente el cáncer colorrectal. Sin embargo, aunque estos hallazgos epidemiológicos son prometedores, se necesitan ensayos clínicos más rigurosos para establecer de manera concluyente los efectos preventivos del salvado sobre estas condiciones. A pesar de algunas limitaciones en la base de evidencia, el salvado sigue siendo un componente dietético muy beneficioso, que ofrece una fuente natural de fibra y nutrientes que contribuyen a la salud y el bienestar general.

Condiciones de Salud

Condiciones de salud que nicotinamida ribósido puede ayudar a apoyar.

  • Nicotinamide riboside (NR), a form of vitamin B3 and NAD+ precursor, was tested in a registered clinical trial (NCT03489200) in ALS patients supplementing a Mediterranean diet. The trial assessed NR combined with pterostilbene versus placebo on anthropometric variables in 40 ALS subjects. NR's rationale is based on combating oxidative stress and mitochondrial dysfunction in ALS.

  • HipocondríaCientífico

    NR supports antioxidant defense primarily by replenishing NADPH—the key reducing equivalent for glutathione regeneration—and by activating sirtuin-mediated antioxidant pathways. A human study found that single 500 mg NR doses depressed markers of oxidative damage while increasing NADPH in older individuals. In heart failure patients, NR-mediated NAD+ increase correlated with improved mitochondrial respiration and reduced oxidative stress markers.

  • Human clinical trials have shown NR supplementation can lower systolic blood pressure and reduce aortic stiffness (measured by carotid-femoral pulse wave velocity), particularly in middle-aged and older adults with elevated baseline blood pressure. A 6-week randomized, double-blind, placebo-controlled crossover trial demonstrated a −4 mmHg reduction in SBP and a −42 cm/s reduction in pulse wave velocity. A subsequent Phase IIa RCT specifically targets adults with elevated-to-stage-1 hypertension to confirm these findings. Evidence is preliminary but mechanistically coherent.

  • HipotensiónCientífico

    Multiple human trials report that NR supplementation produces modest reductions in systolic and diastolic blood pressure, especially in individuals with above-normal baseline SBP. The largest pilot RCT observed an 8 mmHg reduction in systolic BP in the elevated-SBP subgroup after 6 weeks at 1,000 mg/day. A dedicated Phase IIa RCT (NCT03821623) is underway to confirm efficacy at 1,000 mg/day over 3 months.

  • HisteriaCientífico

    NR is an orally bioavailable NAD+ precursor that dose-dependently and reliably elevates whole-blood NAD+ levels in humans—the central cofactor of cellular energy metabolism. In an 8-week RCT, doses of 100, 300, and 1,000 mg/day increased whole-blood NAD+ by 22%, 51%, and 142% respectively. NR's role as a substrate for mitochondrial redox reactions underpins its classification as a cellular energy support compound.

  • NR was directly tested in a large RCT for chronic fatigue in the context of long-COVID, where it raised NAD+ levels within 5 weeks but did not significantly improve fatigue versus placebo at the primary endpoint. Exploratory analyses suggested within-group benefits after 10 weeks. Additionally, NR's core mechanism—replenishing NAD+ for mitochondrial oxidative phosphorylation—provides a plausible basis for energy support in states of NAD+ depletion.

  • ApendicitisCientífico

    Clinical trials have shown NR supplementation reduces circulating inflammatory cytokines in humans. In a randomized, double-blind, placebo-controlled crossover trial of 12 aged men supplemented with 1 g/day NR for 21 days, NR significantly depressed levels of circulating inflammatory cytokines. In heart failure patients, NR at 2 g/day correlated with decreased pro-inflammatory cytokine expression in peripheral blood mononuclear cells. These findings are consistent across multiple small human trials.

  • IncontinenciaCientífico

    Nicotinamide riboside (NR) is an orally bioavailable NAD+ precursor investigated for cognitive decline and healthy aging on the basis that NAD+ levels decline with age, impairing mitochondrial bioenergetics, DNA repair, and sirtuin-mediated cellular maintenance in the brain. Multiple completed randomized controlled trials in older adults with mild cognitive impairment or subjective cognitive decline confirm NR safely elevates NAD+ levels, though short-term trials (8–12 weeks) have not yet demonstrated significant improvement in cognitive test scores. Biomarker evidence from neuronal extracellular vesicles and preclinical Alzheimer's models is more encouraging, warranting larger and longer trials.

  • Nicotinamide riboside (NR) is a form of vitamin B3 and a direct precursor to NAD+. Multiple human RCTs demonstrate that NR supplementation significantly elevates blood NAD+ levels, and emerging evidence shows improvements in energy metabolism and physical performance, particularly in older adults.

  • Nicotinamide riboside (NR) is an NAD+ precursor with strong preclinical evidence for RGC protection in multiple mouse models of glaucoma. It enhanced RGC survival in optic nerve crush and ocular hypertension models, and a clinical trial demonstrated improved retinal function in glaucoma patients. NR may offer superior NAD+ bioavailability compared to nicotinamide.

  • BronquitisCientífico

    Nicotinamide riboside (NR) is a vitamin B3 analogue and NAD+ precursor shown in a randomized crossover clinical trial in healthy middle-aged and older adults to safely and significantly elevate blood NAD+ levels. Exploratory evidence suggests potential benefits for blood pressure, vascular function, and metabolic health in aging populations.

  • BulimiaCientífico

    Nicotinamide riboside (NR) is a NAD+ precursor that protects cochlear nerve synapses from noise-induced damage. Weill Cornell research (Cell Metabolism, 2014) showed NR prevented synaptic degeneration and both short- and long-term hearing loss in noise-exposed mice. Multiple subsequent animal studies confirmed NR protects hair cell ribbon synapses, cochlear hair cells, and auditory neurons from noise and age-related damage.

  • JuanetesCientífico

    NAD+ levels are depleted in the failing human heart, and NR supplementation has been studied in clinical trials to restore myocardial NAD+ and improve mitochondrial function in heart failure. A human study of NR at 2 g/day for 12 weeks in ambulatory HFrEF patients found NR was safe, elevated whole-blood NAD+, and correlated with reduced systemic inflammation. Mechanistic studies in LVAD patients are underway to directly assess myocardial NAD+ and mitochondrial function.

  • Human clinical evidence suggests NR with other metabolic cofactors may improve liver health in NAFLD. Post-hoc analysis of a 12-week RCT in obese men showed a suggestion of improved fatty liver in the NR-treated group. Preclinical studies consistently show NR reduces hepatic steatosis, fibrosis, oxidative stress, and lipid accumulation in diet-induced NAFLD models by activating hepatic sirtuin pathways and restoring NAD+ pools.

  • EscalofríosCientífico

    NR was tested in a 24-week RCT for cognitive outcomes in long-COVID patients; it raised NAD+ but did not significantly improve memory or cognition versus placebo at primary endpoints, though exploratory analyses suggested within-group benefits at 10 weeks. In the Parkinson's disease NADPARK trial, NR was associated with altered cerebral metabolism and mild clinical (including cognitive) improvement. Preclinical evidence shows NR enhances cognition via neuroinflammation reduction and synaptic plasticity.

  • Nicotinamide riboside (NR) is an orally bioavailable NAD+ precursor vitamin that reliably raises blood and tissue NAD+ levels in humans in a dose-dependent manner. NAD+ is a central coenzyme in redox reactions underpinning glycolysis, oxidative phosphorylation, and fatty acid oxidation. While preclinical studies show robust metabolic benefits (improved insulin sensitivity, mitochondrial biogenesis, protection against diet-induced obesity), most short-term human RCTs have not replicated these outcomes for insulin sensitivity, resting energy expenditure, or body composition. Longer-term supplementation (5 months) has shown improvements in muscle mitochondrial number and gut microbiota, but overall human evidence for broad metabolic benefit remains limited and mixed.

  • Nicotinamide riboside (NR) is a vitamin B3 analogue and NAD⁺ precursor that supports mitochondrial health by raising cellular NAD⁺ levels, activating sirtuin pathways, and promoting mitochondrial biogenesis. A 5-month RCT in twin pairs showed NR improved muscle mitochondrial number and satellite cell differentiation.

  • NR supplementation has been tested in humans for its effects on skeletal muscle NAD+ and regeneration after injury. A randomized, placebo-controlled human trial explored NR combined with pterostilbene in elderly subjects with experimentally induced muscle injury. NR was shown to reach aged human skeletal muscle and elevate the NAD+ metabolome; animal studies demonstrate enhanced muscle stem cell activity and regeneration via SIRT1-dependent mechanisms.

  • Nicotinamide riboside (NR) is an NAD+ precursor with clinical evidence specifically in chemotherapy-induced peripheral neuropathy. It is listed in authoritative peripheral neuropathy evidence databases alongside methylcobalamin and ALC. Preclinical studies show NR protects dorsal root ganglion neurons from chemotherapy toxicity through NAD+-dependent mitochondrial protection mechanisms.

  • Two phase I randomized controlled trials have directly tested NR in Parkinson's disease patients. The NADPARK study (n=30, 1,000 mg/day for 30 days) showed NR significantly increased cerebral NAD+ levels and was associated with mild clinical improvement. A separate RCT at 3,000 mg/day for 4 weeks also showed significant clinical symptom improvement. A larger 400-person 1-year trial (NOPARK) is ongoing.

  • Nicotinamide riboside (NR) has been tested in a dedicated randomized controlled trial for long COVID (Lancet eClinicalMedicine, 2025; n=58), where it increased NAD+ within 5 weeks and showed exploratory within-group benefits in fatigue, sleep, and depressive symptoms at 10 weeks. NAD+ deficiency is documented in long COVID, and NR is classified as a form of Vitamin B3 under active clinical investigation for post-COVID recovery.

Sistemas Corporales

Sistemas corporales que nicotinamida ribósido puede ayudar a apoyar.

  • No hay sistemas corporales disponibles.
Únete a nuestro boletín

Mantente informado. Mantente saludable.

Recibe consejos de suplementos de expertos, descuentos exclusivos y recomendaciones de productos en tu bandeja de entrada